Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
KOTLER KEVIN (CIK 1601692) reported $427.5M across 34 reported positions in its SEC 13F filing for 2025-12-31. Largest positions: SPY ($238.7M, 55.83%), AVDL ($34.9M, 8.17%), QQQ ($30.7M, 7.18%), ANGO ($22.0M, 5.15%), AUPH ($19.5M, 4.57%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SPY | SPDR S&P 500 ETF TR | $238.7M | 55.83% | 350,000 | New |
| 2 | AVDL | AVADEL PHARMACEUTICALS PLC | $34.9M | 8.17% | 1.6M | New |
| 3 | QQQ | INVESCO QQQ TR | $30.7M | 7.18% | 50,000 | New |
| 4 | ANGO | ANGIODYNAMICS INC | $22.0M | 5.15% | 1.7M | New |
| 5 | AUPH | AURINIA PHARMACEUTICALS INC | $19.5M | 4.57% | 1.2M | New |
| 6 | OMER | OMEROS CORP | $19.3M | 4.53% | 1.1M | New |
| 7 | NPCE | NEUROPACE INC | $9.7M | 2.28% | 631,468 | New |
| 8 | MDWD | MEDIWOUND LTD | $6.2M | 1.46% | 337,236 | New |
| 9 | AXGN | AXOGEN INC | $5.5M | 1.29% | 168,000 | New |
| 10 | IART | INTEGRA LIFESCIENCES HLDGS C | $5.3M | 1.24% | 427,445 | New |
| 11 | ACRS | ACLARIS THERAPEUTICS INC | $5.1M | 1.20% | 1.7M | New |
| 12 | EVTL | VERTICAL AEROSPACE LTD | $5.0M | 1.17% | 939,705 | New |
| 13 | OSUR | ORASURE TECHNOLOGIES INC | $4.4M | 1.02% | 1.8M | New |
| 14 | LKFT | GALAPAGOS NV | $2.9M | 0.69% | 90,000 | New |
| 15 | LLY | ELI LILLY & CO | $2.1M | 0.50% | 2,000 | New |
| 16 | CERS | CERUS CORP | $2.1M | 0.49% | 1.0M | New |
| 17 | NKE | NIKE INC | $2.0M | 0.48% | 32,000 | New |
| 18 | TECX | TECTONIC THERAPEUTIC INC | $1.7M | 0.39% | 80,000 | New |
| 19 | CLYM | CLIMB BIO INC | $1.6M | 0.37% | 400,000 | New |
| 20 | TMCI | TREACE MED CONCEPTS INC | $1.2M | 0.27% | 474,365 | New |
| 21 | TLSI | TRISALUS LIFE SCIENCES INC | $1.0M | 0.24% | 145,200 | New |
| 22 | DXCM | DEXCOM INC | $995,550 | 0.23% | 15,000 | New |
| 23 | VNDA | VANDA PHARMACEUTICALS INC | $882,000 | 0.21% | 100,000 | New |
| 24 | ALGN | ALIGN TECHNOLOGY INC | $680,658 | 0.16% | 4,359 | New |
| 25 | OKUR | ONKURE THERAPEUTICS INC | $573,304 | 0.13% | 197,691 | New |
Source: SEC Form 13F filings · as of 2025-12-31